---
figid: PMC10376118__biology-12-01042-g002
pmcid: PMC10376118
image_filename: biology-12-01042-g002.jpg
figure_link: /pmc/articles/PMC10376118/figure/biology-12-01042-f002/
number: Figure 2
figure_title: ''
caption: 'Rosiglitazone (RSG) modulating the expression of neural brain-derived neurotrophic
  factor (BDNF) through [] peroxisome proliferator-activated receptor-gamma (PPARγ)-mediated
  transcriptional regulation and [] upregulation of the cyclic AMP-response element
  binding protein (CREB)/BDNF/tropomyosin receptor kinase B (TrkB) pathway. Created
  with BioRender.com (accessed 30 April 2023, license agreement: KA25B75AY7).'
article_title: Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through
  the Modulation of Brain-Derived Neurotrophic Factor.
citation: Mackayla L. Nelson, et al. Biology (Basel). 2023 Jul;12(7):1042.
year: '2023'

doi: 10.3390/biology12071042
journal_title: Biology
journal_nlm_ta: Biology (Basel)
publisher_name: MDPI

keywords:
- rosiglitazone
- brain-derived neurotrophic factor
- Alzheimer’s disease
- clinical trials
- peroxisome proliferator-activated receptor-gamma
- type 2 diabetes mellitus
- review

---
